Down's Syndrome Market To Exhibit Growth At A CAGR Of 3.81% By 2034 Delveinsight
(MENAFN- PR Newswire) According to DelveInsight's analysis, the market for Down syndrome is anticipated to increase during the forecast period (2024–2034), owing to the launch of emerging therapies such as AEF0217, ACI-24.060, LEUCETTINIB-21, …